GlassScriptPhysician profile
Syed S Ali
NPI 1245404755
$4,378.68
in general payments reported to CMS, 2019-2025
15 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,799 · 2020: $28.97 · 2021: $42.12 · 2022: $19.86 · 2023: $86.45 · 2024: $177 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $3,382.16 | 2019-2021 | |
| Abbott Laboratories | $160.31 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic USA, INC. | $118.99 | 2019 | |
| Boston Scientific Corporation | $114.46 | 2025 | Intracept |
| Stryker Corporation | $102.00 | 2019-2022 | |
| Lilly USA, LLC | $91.60 | 2019 | |
| Abiomed | $80.24 | 2025 | |
| Radius Health, INC. | $78.87 | 2019 | |
| Nevro Corp. | $59.26 | 2019-2020 | |
| Allergan, INC. | $57.54 | 2019-2021 | |
| Abbvie INC. | $36.87 | 2023 | Botox |
| Globus Medical, INC. | $30.53 | 2025 | Senza |
| Axonics, INC. | $25.38 | 2024 | Axonics |
| Painteq LLC | $24.74 | 2023 | Painteq |
| Novo Nordisk INC | $15.73 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.